A detailed history of Vital Stone Financial, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Vital Stone Financial, LLC holds 30 shares of LNTH stock, worth $2,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Holding current value
$2,739
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$77.7 - $123.62 $2,331 - $3,708
30 New
30 $3,000
Q3 2023

Nov 15, 2023

SELL
$60.27 - $90.75 $510,547 - $768,743
-8,471 Reduced 99.57%
37 $2,000
Q2 2023

Aug 21, 2023

BUY
$82.41 - $99.65 $701,144 - $847,822
8,508 New
8,508 $696,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.